Associations between length of follow-up and change in primary outcome and significant secondary outcomes in the GSD intervention group
| n | Time to follow-upa Mean (SD) | Change Mean (SD) | Bb | p Value | |
| HbA1c, % | 87 | 16.1 (5.6) | −0.51 (1.21) | −0.03 | 0.154 |
| PAIDc | 47 | 17.6 (3.6) | −6.7 (13.8) | −0.2 | 0.764 |
| DDSdoverall | 47 | 17.6 (3.6) | −5.4 (14.0) | −0.4 | 0.542 |
| DDS emotional burden | 48 | 17.6 (3.6) | −7.1 (20.1) | 0.1 | 0.945 |
| RSESe | 47 | 17.6 (3.6) | 0.6 (3.5) | −0.1 | 0.435 |
| TSRQ autonomyf | 49 | 17.6 (3.6) | 0.2 (0.9) | 0.03 | 0.388 |
a Total follow-up time from date of randomization measured in months, bB=unstandardized regression coefficients, cProblem Areas in Diabetes scale, dDiabetes Distress Scale, eRosenberg Self-Esteem Scale, fTreatment SelfRegulation Questionnaire, Autonomous motivation.
GSD, guided self-determination;